Redondo-Castillejo Rocío, Hernández-Martín Marina, Issa-García Jousef Ángel, Bocanegra Aránzazu, Garcimartín Alba, Macho-González Adrián, Bastida Sara, Sánchez-Muniz Francisco J, Benedí Juana, López-Oliva M Elvira
Pharmacology, Pharmacognosy and Botany Department, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain.
Departmental Section of Physiology, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain.
Nutrients. 2025 Jul 28;17(15):2452. doi: 10.3390/nu17152452.
BACKGROUND/OBJECTIVES: Diatomaceous earth (DE), a natural substance rich in amorphous silica and recognized as a food additive, is gaining attention as a dietary silicon supplement. However, its bioavailability and impact on lipid digestion and absorption remain poorly characterized. This study aimed to investigate silicon bioavailability after short-term DE supplementation and its effects on postprandial glycemia and triglyceridemia, the expression of lipid metabolism-related proteins, and the modulation of the intestinal mucosal barrier.
Female Wistar rats received daily oral supplementation of DE (equivalent to 2 or 4 mg silicon/kg body weight) for one week. Silicon digestibility, excretion, and hepatic accumulation were quantified. Postprandial glycemia and triglyceridemia were monitored. Lipid profile was analyzed by HPSEC in gastric and intestinal contents. Jejunal morphology and mucin-secreting cells were assessed histologically. Lipid metabolism markers were evaluated by immunohistochemistry and Western blot in both intestinal and hepatic tissues.
DE supplementation enhanced silicon absorption and increased hepatic levels. Fecal output and moisture content were also elevated, especially at the higher dose. DE significantly reduced postprandial triglyceridemia and consequently increased luminal triglyceride retention. These changes were associated with decreased jejunal levels of IFABP, ACAT2, and MTP, as well as reduced hepatic levels of MTP and LDLr, alongside increased levels of ABCG5/G8 and LXRα/β, indicating a partial blockage of lipid absorption and enhanced cholesterol efflux. The effects on the intestinal barrier were evidenced by villi shortening and an increase in mucin-producing cells.
Food-grade DE is a bioavailable source of silicon with hypolipidemic potential, mainly by reducing intestinal lipid absorption. This is supported by lower postprandial triglycerides, increased luminal lipid retention, and decreased expression of lipid transport proteins. The study in healthy female rats underscores the importance of sex-specific responses and supports DE as a dietary strategy to improve lipid metabolism.
背景/目的:硅藻土(DE)是一种富含无定形二氧化硅的天然物质,被公认为食品添加剂,作为膳食硅补充剂正受到关注。然而,其生物利用度以及对脂质消化和吸收的影响仍未得到充分表征。本研究旨在探讨短期补充DE后硅的生物利用度及其对餐后血糖和甘油三酯血症、脂质代谢相关蛋白表达以及肠道黏膜屏障调节的影响。
雌性Wistar大鼠每日口服补充DE(相当于2或4毫克硅/千克体重),持续一周。对硅的消化率、排泄和肝脏蓄积进行定量分析。监测餐后血糖和甘油三酯血症。通过高效体积排阻色谱法分析胃和肠道内容物中的脂质谱。对空肠形态和黏蛋白分泌细胞进行组织学评估。通过免疫组织化学和蛋白质免疫印迹法评估肠道和肝脏组织中的脂质代谢标志物。
补充DE可提高硅的吸收并增加肝脏中的含量。粪便排出量和水分含量也有所升高,尤其是在高剂量时。DE显著降低餐后甘油三酯血症,从而增加管腔内甘油三酯的潴留。这些变化与空肠中脂肪酸结合蛋白(IFABP)、酰基辅酶A胆固醇酰基转移酶2(ACAT2)和微粒体甘油三酯转运蛋白(MTP)水平降低以及肝脏中MTP和低密度脂蛋白受体(LDLr)水平降低有关,同时ATP结合盒转运体G5/G8(ABCG5/G8)和肝X受体α/β(LXRα/β)水平升高,表明脂质吸收部分受阻且胆固醇外流增加。对肠道屏障的影响表现为空肠绒毛缩短和黏蛋白产生细胞增加。
食品级DE是一种具有生物利用度的硅来源,具有降血脂潜力,主要通过减少肠道脂质吸收实现。餐后甘油三酯降低、管腔内脂质潴留增加以及脂质转运蛋白表达降低均支持这一结论。在健康雌性大鼠中的研究强调了性别特异性反应的重要性,并支持将DE作为改善脂质代谢的膳食策略。